BACKGROUND
Hypothyroidism, or underactivity of the thyroid gland, comes in 2 general forms: primary hypothyroidism (high TSH and low T4) and secondary hypothyroidism (low/ normal TSH, low T4 and T3). Primary hypothyroidism is most commonly caused by an autoimmune thyroid disease called Hashimoto’s thyroiditis which causes destruction of the thyroid gland. Primary hypothyroidism can also be caused by pregnancy, minor illnesses, lithium, surgery, and some medications like tyrosine kinase inhibitors used to treat thyroid and other cancers. Secondary hypothyroidism occurs when the pituitary gland in the head cannot send the thyroid gland in the neck enough TSH.
This study was done to see if TSH levels that are monitored during the treatment of both types of hypothyroidism are significantly changed when switching to/from generic or brand name formulations of levothyroxine hormone replacement therapy. This study is challenging because of weight, absorption, compliance, and medication interaction changes that might alter TSH values regardless of the medication itself. The goal of this study is to look at the frequency of normal TSH values and likelihood of abnormal TSH values when different levothyroxine preparations are taken.
THE FULL ARTICLE TITLE
Bianco AC et al Levothyroxine Treatment Adequacy and Formulation Changes in Patients With Hypothyroidism: A Retrospective Study of Real-World Data From the United States Thyroid, 2023, online.
SUMMARY OF THE STUDY
Patients diagnosed with either primary or secondary hypothyroidism between the years of 2013 and 2020 were randomly chosen from a medical database. Patients were chosen mostly from the clinic setting with at least two TSH values spaced at least 1-15 months apart were included, and those who switched levothyroxine formulations were identified.